中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

109 records (took 0.027 seconds)

    탄닌 또는 탄닌 유래 페놀성 화합물을 포함하는동맥경화증, 고지혈증 및 지방간의 예방 및 치료용 식품조성물
    3.
    发明公开
    탄닌 또는 탄닌 유래 페놀성 화합물을 포함하는동맥경화증, 고지혈증 및 지방간의 예방 및 치료용 식품조성물 无效
    食品复合材料用于预防和治疗阿片样物质，高胆固醇和包括鞣制或鞣制酚醛化合物的肝硬化

    公开(公告)号：KR1020010030556A

    公开(公告)日：2001-04-16

    申请号：KR1020000062335

    申请日：2000-10-23

    Applicant: 한국과학기술연구원

    Inventor： 복성해 ,  정태숙 ,  배기환 ,  박용복 ,  최명숙 ,  문석식 ,  권용국 ,  이은숙 ,  현병화 ,  최양규 ,  이철호 ,  안병태 ,  이새봄

    IPC: A23L1/29 ,  A61K36/00 ,  A23L2/00

    Abstract: PURPOSE: Food composites including tannin or tannin-derived phenolics are provided to prevent and treat arteriosclerosis, hyperlipidemia and hepatic steatosis by dosing tannin, gallic acid or/and ellagic acid. CONSTITUTION: Tannin, gallic acid or/and ellagic acid is/are added to a food or a drink to prevent and treat arteriosclerosis. Tannin(C76H52O46) is extracted from acorns, persimmons and walnut shells. Gallic acid(C7H6O5) and ellagic acid(C14H6O8) are the decomposition products of tannin and have anticancer activities. The amount of the tannin-derived phenolics is from 0.01wt.% to 20wt.% according to the weight, age, gender, health status, diet, dosage time and method, excretory rate and disease level of patients.

    Abstract translation: 目的：提供包括单宁或单宁衍生物酚类的食品复合材料，以预防和治疗单宁，没食子酸或鞣花酸的动脉硬化，高脂血症和肝脂肪变性。 构成：将单宁，没食子酸或/和鞣花酸加入到食物或饮料中以预防和治疗动脉硬化。 单宁（C76H52O46）从橡子，柿子和核桃壳中提取。 没食子酸（C7H6O5）和鞣花酸（C14H6O8）是单宁的分解产物，具有抗癌活性。 根据体重，年龄，性别，健康状况，饮食，剂量时间和方法，患者的排泄率和病情水平，单宁衍生物酚类的含量为0.01重量％〜20重量％。

    엘라그산을 포함하는 동맥경화증, 고지혈증 및 지방간의예방 및 치료용 조성물
    4.
    发明公开
    엘라그산을 포함하는 동맥경화증, 고지혈증 및 지방간의예방 및 치료용 조성물 失效
    含有鞣制，酸性或非酸性的组合物，用于预防和治疗肠梗塞，高血压和肝脏疾病

    公开(公告)号：KR1020010015510A

    公开(公告)日：2001-02-26

    申请号：KR1020000062334

    申请日：2000-10-23

    Applicant: 한국과학기술연구원

    Inventor： 복성해 ,  정태숙 ,  배기환 ,  박용복 ,  최명숙 ,  문석식 ,  권용국 ,  이은숙 ,  현병화 ,  최양규 ,  이철호 ,  안병태 ,  이새봄

    IPC: A61K31/366

    Abstract: PURPOSE: A composition containing tannin, gallic acid or ellagic acid is provided for preventing and treating arteriosclerosis, hyperlipemia and liver diseases. CONSTITUTION: When tannin, gallic acid or ellagic acid are administrated into an animal body, they prevent the deposition of macrophage-lipid complex within the inner surface of arterial duct, decrease the concentration of GOT(glutamate-oxaloacetate transaminase), GPT(glutamate-pyruvate transaminase), gammaGTP(gamma-glutamyl transpeptidase), and lipid in serum, and strongly inhibit the damage of liver cells and the progress of fatty liver. The composition contains an effective of ellagic acid displaying an anticancer activity, that is 0.1 mg to 500 mg/weight kg a day. The composition is preferably administrated into an animal body 5 times a day in a dosage of 1 mg to 100 mg/weight kg.

    Abstract translation: 目的：提供含有单宁，没食子酸或鞣花酸的组合物，用于预防和治疗动脉硬化，高脂血症和肝脏疾病。 构成：当将单宁，没食子酸或鞣花酸施用于动物体内时，可防止巨噬细胞 - 脂质复合物在动脉管内表面沉积，降低GOT（谷氨酸 - 草酰乙酸转氨酶）浓度，GPT（谷氨酸 - 丙酮酸转氨酶），γGTP（γ-谷氨酰转肽酶）和血清中的脂质，并且强烈地抑制肝细胞的损伤和脂肪肝的进展。 组合物含有显示抗癌活性的有效的鞣花酸，即每天0.1mg至500mg /重量kg。 组合物优选以1mg至100mg / kg kg的剂量每天施用5次。

    루틴 및 쿼세틴을 포함하는 고지혈증, 동맥경화증 및 간질환의 예방 및 치료용 조성물
    5.
    发明公开
    루틴 및 쿼세틴을 포함하는 고지혈증, 동맥경화증 및 간질환의 예방 및 치료용 조성물 无效
    含有脯氨酸和奎宁的预防和治疗高脂血症，肠梗塞和肝病的药物组合物

    公开(公告)号：KR1020010015495A

    公开(公告)日：2001-02-26

    申请号：KR1020000058705

    申请日：2000-10-06

    Applicant: 한국과학기술연구원

    Inventor： 복성해 ,  정태숙 ,  배기환 ,  박용복 ,  최명숙 ,  문석식 ,  권용국 ,  이은숙 ,  이준성 ,  현병화 ,  최양규 ,  이철호 ,  안병태 ,  이새봄

    IPC: A23L1/29

    Abstract: PURPOSE: A pharmaceutical composition containing one of rutin and Quercetin or the mixture is provided to prevent and treat hyperlipidemia, arteriosclerosis and liver diseases. CONSTITUTION: The rutin is extracted from buckwheat or leaves, stems and flowers of the buckwheat by leaving the materials at a base of pH10-12 by using calcium hydroxide, neutralizing and settling the materials, or by using 20-97% alcohol or water at a high temperature and pressure. The buckwheat and the leaves, stems and flowers also can be dried and pulverized to get powdered buckwheat. The resulting buckwheat flour or buckwheat extract containing 0.01-10wt% of the rutin, quercetin or the mixture of them is added to tomato ketchup, sauce and juice, ramen, noodle, bread, cookies and cracker, soup and gravies, ground beef, or dairy products to get functional foods.

    Abstract translation: 目的：提供含有芦丁和槲皮素之一或混合物的药物组合物，用于预防和治疗高脂血症，动脉硬化和肝脏疾病。 构成：通过使用氢氧化钙将材料置于pH10-12的碱性条件下，从荞麦或荞麦的荞麦或叶子，茎和花中提取芦丁，中和和沉淀材料，或通过使用20-97％的酒精或水 高温高压。 荞麦和叶子，茎和花也可以干燥和粉碎以得到荞麦粉。 将含有0.01-10重量％的芦丁，槲皮素或其混合物的荞麦面粉或荞麦提取物加入番茄酱，酱汁和果汁，拉面，面条，面包，饼干和饼干，汤和肉汁，碎牛肉或 乳制品获得功能性食品。

    신규한 페니실리움 그리세오플범 생산균주와 콜레스테롤 대사억제제의 생산
    6.
    发明授权
    신규한 페니실리움 그리세오플범 생산균주와 콜레스테롤 대사억제제의 생산 失效
    空值

    公开(公告)号：KR100264392B1

    公开(公告)日：2000-08-16

    申请号：KR1019980003012

    申请日：1998-02-04

    Applicant: 한국과학기술연구원

    Inventor： 김영국 ,  김미경 ,  권병목 ,  정태숙 ,  김성욱 ,  최도일 ,  황인규 ,  손광희 ,  복성해

    IPC: C12N1/20

    Abstract: PURPOSE: A microorganism, Penicillium griseofulvum, producing pyripyropene A and a method for producing cholesterol metabolism inhibitor are provided, wherein pyripyropene A inhibits the activity of cholesterol acyltransferase(ACAT) which adsorbs cholesterol into blood, and is thus used in decreasing the blood cholesterol concentration. CONSTITUTION: Penicillium griseofulvum F1959 separated from soil by Samson method produces pyripyropene A which inhibits the activity of cholesterol acyltransferase(ACAT) and its inhibition concentration IC50 is about 35 ng/ml which is calculated by the equation. The ACAT inhibitor pyripyropene A is produced by the steps of: incubating Penicillium griseofulvum F1959 in a spawn medium containing 0.5% of glucose, 0.2% of yeast extract, 0.5% of polypeptone, 0.1% of potassium phosphate and 0.05% of magnesium sulfate at 29 deg. C for 18 hours; and incubating the microorganism in a growth medium containing 2% of starch, 0.4% of soytone, 0.3% of pama media, 0.1% of potassium phosphate, 0.05% of magnesium sulfate, 0.3% of calcium carbonate and 0.2% of sodium chloride at 29 deg. C for 120 hours.

    Abstract translation: 目的：提供微生物青霉菌青霉菌，产生吡柔比星A和生产胆固醇代谢抑制剂的方法，其中吡哆灵A抑制胆固醇酰基转移酶（ACAT）的活性，胆固醇酰基转移酶（ACAT）将胆固醇吸附到血液中，因此用于降低血液胆固醇浓度 。 构成：通过Samson方法从土壤中分离的灰黄霉菌F1959产生抑制胆固醇酰基转移酶（ACAT）活性的白藜芦醇A，其抑制浓度IC50为约35ng / ml，其通过该方程式计算。 通过以下步骤制备ACAT抑制剂pyripyropene A：在含有0.5％葡萄糖，0.2％酵母提取物，0.5％多聚蛋白胨，0.1％磷酸钾和0.05％硫酸镁的产卵培养基中将灰黄青霉F1959温育于29℃ 度。 C 18小时; 并在29℃下将微生物培养在含有2％淀粉，0.4％大豆油，0.3％帕马培养基，0.1％磷酸钾，0.05％硫酸镁，0.3％碳酸钙和0.2％氯化钠的生长培养基中 度。 C 120小时。

Patent Agency Ranking